Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 11 studies | 57% ± 19% | |
oligodendrocyte precursor cell | 10 studies | 42% ± 15% | |
GABAergic neuron | 8 studies | 50% ± 26% | |
glutamatergic neuron | 7 studies | 34% ± 18% | |
interneuron | 5 studies | 71% ± 15% | |
neuron | 4 studies | 24% ± 6% | |
retina horizontal cell | 4 studies | 22% ± 8% | |
retinal ganglion cell | 4 studies | 39% ± 17% | |
endothelial cell | 3 studies | 42% ± 16% | |
granule cell | 3 studies | 20% ± 4% | |
microglial cell | 3 studies | 39% ± 11% | |
glycinergic amacrine cell | 3 studies | 27% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 12 studies | 38% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 816.20 | 2624 / 2642 | 82% | 4.33 | 578 / 705 |
adrenal gland | 98% | 1076.86 | 252 / 258 | 81% | 14.87 | 186 / 230 |
prostate | 94% | 634.13 | 230 / 245 | 81% | 4.04 | 409 / 502 |
ovary | 89% | 787.68 | 161 / 180 | 6% | 0.16 | 25 / 430 |
skin | 28% | 223.17 | 507 / 1809 | 58% | 11.17 | 273 / 472 |
kidney | 12% | 25.66 | 11 / 89 | 63% | 6.43 | 572 / 901 |
uterus | 36% | 223.33 | 62 / 170 | 20% | 0.69 | 92 / 459 |
bladder | 48% | 271.10 | 10 / 21 | 9% | 0.20 | 43 / 504 |
pancreas | 14% | 18.73 | 47 / 328 | 33% | 0.70 | 59 / 178 |
tonsil | 0% | 0 | 0 / 0 | 42% | 2.25 | 19 / 45 |
adipose | 34% | 46.70 | 412 / 1204 | 0% | 0 | 0 / 0 |
breast | 20% | 26.37 | 93 / 459 | 5% | 0.19 | 53 / 1118 |
eye | 0% | 0 | 0 / 0 | 21% | 0.54 | 17 / 80 |
thymus | 17% | 20.34 | 109 / 653 | 2% | 0.05 | 13 / 605 |
lung | 7% | 10.31 | 39 / 578 | 11% | 0.42 | 130 / 1155 |
esophagus | 0% | 0.28 | 3 / 1445 | 9% | 0.31 | 17 / 183 |
intestine | 5% | 5.89 | 45 / 966 | 4% | 0.10 | 22 / 527 |
liver | 0% | 0 | 0 / 226 | 8% | 0.19 | 31 / 406 |
stomach | 0% | 0.26 | 1 / 359 | 5% | 0.11 | 13 / 286 |
heart | 3% | 3.35 | 26 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 0.73 | 9 / 1335 | 0% | 0 | 0 / 0 |
spleen | 0% | 0.42 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0061590 | Biological process | calcium activated phosphatidylcholine scrambling |
GO_0034220 | Biological process | monoatomic ion transmembrane transport |
GO_0061589 | Biological process | calcium activated phosphatidylserine scrambling |
GO_0061591 | Biological process | calcium activated galactosylceramide scrambling |
GO_1902476 | Biological process | chloride transmembrane transport |
GO_0051649 | Biological process | establishment of localization in cell |
GO_0005886 | Cellular component | plasma membrane |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005229 | Molecular function | intracellularly calcium-gated chloride channel activity |
GO_0017128 | Molecular function | phospholipid scramblase activity |
Gene name | ANO4 |
Protein name | Anoctamin-4 (Transmembrane protein 16D) Anoctamin 4 Anoctamin |
Synonyms | TMEM16D |
Description | FUNCTION: Has calcium-dependent phospholipid scramblase activity; scrambles phosphatidylserine, phosphatidylcholine and galactosylceramide (By similarity). Does not exhibit calcium-activated chloride channel (CaCC) activity (By similarity). . |
Accessions | ENST00000575847.8 F8VW62 ENST00000644049.1 A0A2R8Y532 ENST00000392977.8 [Q32M45-1] ENST00000549155.6 F8VUH1 ENST00000573650.8 ENST00000392979.7 [Q32M45-2] Q32M45 ENST00000546991.1 ENST00000570509.4 |